A Phase I/IIa Study of SYS6041 in Patients With Advanced Solid Tumors

NCT07744763 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SYS6041

Sponsor

CSPC Megalith Biopharmaceutical Co.,Ltd.